ConductScience.org, home

Paper39794860

Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021.

Li T and 8 others. J Hematol Oncol, 2025. Cited by 164 papers, by iCite.

Cite this record

ConductScience Library. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. Papers, record 39794860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39794860

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
164
iCite
Relative citation ratio, by iCite
45.5, provisional
iCite
Revised in PubMed
2026-11-04
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li TTianye
2Zhang HHaoxiang
3Lian MMengyi
4He QQionghua
5Lv MMingwei
6Zhai LLingyun
7Zhou JJianwei
8Wu KKongming
9Yi MMing

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Uterine Cervical NeoplasmsMajor topic
Ovarian NeoplasmsMajor topic
Breast NeoplasmsMajor topic
Uterine NeoplasmsMajor topic
Humans
Female
Risk Factors
Global Burden of Disease
Global Health
Incidence
Middle Aged
Adult
Disability-Adjusted Life Years
Aged

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2023M743016China Postdoctoral Science FoundationPubMed
2022M722766China Postdoctoral Science FoundationPubMed
82403929National Natural Science Foundation of ChinaPubMed
LQ24H160007Natural Science Foundation of Zhejiang ProvincePubMed
GZB20230642Postdoctoral Fellowship Program of CPSFPubMed

Source PubMed

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136878567Updates on cervical cancer prevention.Int J Gynecol Cancer2023https://conductscience.org/library/papers/36878567PubMed
237641116Recent advances in targeted strategies for triple-negative breast cancer.J Hematol Oncol2023https://conductscience.org/library/papers/37641116PubMed
326546245Active and passive smoking and risk of breast cancer: a meta-analysis.Breast Cancer Res Treat2015https://conductscience.org/library/papers/26546245PubMed
434332564Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018).BMC Cancer2021https://conductscience.org/library/papers/34332564PubMed
538762324Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet2024https://conductscience.org/library/papers/38762324PubMed
620634209Tubal ligation and the risk of ovarian cancer: review and meta-analysis.Hum Reprod Update2011https://conductscience.org/library/papers/20634209PubMed
738642570
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet2024https://conductscience.org/library/papers/38642570PubMed
833168565Treatment of epithelial ovarian cancer.BMJ2020https://conductscience.org/library/papers/33168565PubMed
932031879Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.J Clin Oncol2020https://conductscience.org/library/papers/32031879PubMed
1038606827Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).J Gynecol Oncol2024https://conductscience.org/library/papers/38606827PubMed
1132981178A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese.Cancer Sci2020https://conductscience.org/library/papers/32981178PubMed
1238582094
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet2024https://conductscience.org/library/papers/38582094PubMed
1325800123A systematic review and meta-analysis of physical activity and endometrial cancer risk.Eur J Epidemiol2015https://conductscience.org/library/papers/25800123PubMed
1438572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1532472674Transiently increased risk of breast cancer after childbirth: implications for fertility treatments and surrogacy.Hum Reprod2020https://conductscience.org/library/papers/32472674PubMed
1638762327Findings from the Global Burden of Disease Study 2021.Lancet2024https://conductscience.org/library/papers/38762327PubMed
1736460337Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer.J Immunother Cancer2022https://conductscience.org/library/papers/36460337PubMed
1838081139NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.J Natl Compr Canc Netw2023https://conductscience.org/library/papers/38081139PubMed
1934233747Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study.Biomark Res2021https://conductscience.org/library/papers/34233747PubMed
2032513227The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.J Hematol Oncol2020https://conductscience.org/library/papers/32513227PubMed

See all 32 referencesDownload CSV of references

Cited by142

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.

PMIDTitleJournalYearIn PapersSource
42938830Beyond Platinum Resistance: Reconsidering Platinum Sensitivity as a Dynamic Phenotype in Ovarian Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42938830PubMed
42935697Global, Regional, and National Burden of Ovarian Cancer Among Women of Reproductive Age, 1990-2021, with Projections to 2040: A Global Burden of Disease Study 2021 Analysis.Int J Womens Health2026https://conductscience.org/library/papers/42935697PubMed
42920161Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment.Arch Public Health2026https://conductscience.org/library/papers/42920161PubMed
42910745Exploring Vitamin D Metabolism in Gynaecological Malignancies: Redox-Dependent and Redox-Independent Anticancer Mechanisms From Preclinical Models to Clinical Evidence.Cancer Med2026https://conductscience.org/library/papers/42910745PubMed
42908789Global, regional and national cancer burden and trends of middle-aged and older populations: a GBD 2021-based analysis, prediction and prevention.Front Oncol2026https://conductscience.org/library/papers/42908789PubMed
42830779Character strengths, psychological distress, anxiety, and depression in adolescents and young adults with gynecologic cancer: A network analysis.Asia Pac J Oncol Nurs2026https://conductscience.org/library/papers/42830779PubMed
42807817HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design.Front Immunol2026https://conductscience.org/library/papers/42807817PubMed
42752778Burden of cancer in China from 1990 to 2023 and projections to 2050.Sci China Life Sci2026https://conductscience.org/library/papers/42752778PubMed
42713453The use of MRI in the diagnosis of ovarian cancer.Front Med (Lausanne)2026https://conductscience.org/library/papers/42713453PubMed
42682456Virtual MR elastography and continuous-time random walk for predicting Ki-67 status in cervical cancer: a preliminary study.Front Oncol2026https://conductscience.org/library/papers/42682456PubMed
42680981Worldwide changes in the burden of deciduous and permanent tooth caries and periodontal disease in children and adolescents aged 0-19 years from 1990 to 2021.Clin Oral Investig2026https://conductscience.org/library/papers/42680981PubMed
42676940Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms.Front Cell Dev Biol2026https://conductscience.org/library/papers/42676940PubMed
42635979CHST1 Drives Immunotherapy Resistance in Triple-Negative Breast Cancer by Orchestrating an Immunosuppressive Microenvironment via the NKRF-CCL20-Macrophage Axis.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42635979PubMed
42625591Female cancers in adolescent and young adult women: global inequities and 2050 burden estimates from GLOBOCAN 2022.Front Oncol2026https://conductscience.org/library/papers/42625591PubMed
42621676The Choice Between Definitive Radiotherapy and Surgery for Cervical Cancer With Different Histology in Current Clinical Practice.Kaohsiung J Med Sci2026https://conductscience.org/library/papers/42621676PubMed
42597475Actin-related protein 2/3 complex subunit 1B promotes cervical cancer cell tumorigenesis in vitro and in vivo.Am J Cancer Res2026https://conductscience.org/library/papers/42597475PubMed
42568605COVID-19 vaccination rates as a proxy for health system resilience: implications of development disparities for cervical cancer control during the pandemic.Front Med (Lausanne)2026https://conductscience.org/library/papers/42568605PubMed
42504307Suppressing M2 Macrophage Polarization by Glycine Combined with β-Elemene via the IL-6/JAK2/STAT3 Signaling Pathway to Inhibit Triple-Negative Breast Cancer Progression.Breast Cancer (Dove Med Press)2026https://conductscience.org/library/papers/42504307PubMed
42500684Single-cell and spatial profiling reveal an IL-10-associated iCAF-M2 macrophage communication axis in high-grade serous ovarian cancer ascites.Front Immunol2026https://conductscience.org/library/papers/42500684PubMed
42474716Deep learning reconstruction versus conventional parallel imaging for sagittal T2-weighted MRI in cervical cancer: a comparison of acceleration factors.Abdom Radiol (NY)2026https://conductscience.org/library/papers/42474716PubMed

See all 142 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39794860

GET https://conductscience.org/api/papers/v1/39794860/references?page=2